First elected: 2019
Year of birth: 1956
Carl-Johan Spak is Senior Advisor at Flerie Invest. Carl-Johan was employed in senior positions at Recipharm between 2009 and April 2021. Prior to that, Carl-Johan has been head of Meda’s Nordic organization and CEO of Recip AB. He is currently engaged as a board member of several life science companies, both in Sweden and internationally. Carl-Johan has a basic education as a dentist and a PhD in cariology and pharmacology at Karolinska Institutet in 1984.
Independence: Independent of the Company and the Executive Management and independent of major shareholders.
Other Board Assignments: Atrogi AB, XSpray Pharma AB (publ), Symcel AB, Buzzard Pharmaceuticals AB, KAHR Medical Ltd, Israel, EpiEndo Pharmaceuticals EHF, Iceland, Provell Pharmaceuticals LLC, USA and Lipum AB.
Holdings: 27 381 shares.